MWG Biotech AG announces expansion of their UK and Ireland sales team

Ebersberg, (PresseBox) - As part of their on-going investment in the Oligonucleotides and Sequencing market in the UK and Ireland, MWG Biotech today announced the expansion of their sales team.

Avril Hamilton joins as UK and Ireland Sales Manager and her appointment is seen as key to strengthening the sales and marketing activities of the UK unit. Krish Sakhamuru joins the team as the new Key Account salesperson for the UK South territory. Avril Hamilton was previously Senior European Territory Manager for Cogenics and formerly held senior sales positions at PerkinElmer and BioRad. Krish Sakhamuru has held account manager positions with Elsevier MDS and InforMax (Invitrogen).

MWG Biotech successfully implemented the new sequencing technology based on the Genome Sequencer 20 system at the end of 2006 and have recently added gene synthesis and gene evolution library generation to their range of services.

Dr. Stefan Blickling, European Sales Director said - This is an excellent step towards cementing MWG Biotech as a leading provider of high quality molecular biology services across all of Europe.
In a time where most service business is conducted via the internet, we firmly believe that a personal presence and local support is of paramount importance.

Eurofins Genomics GmbH

MWG Biotech AG, headquartered in Ebersberg, Germany, is an international provider of DNA sequencing services, DNA/siRNA synthesis products, gene synthesis and bioinformatic services for academic and industrial research.
With production sites in Germany, the US, and India the company’s strength is its strong customer orientation, fast service and high quality products including a series of advanced oligonucleotide and siRNA design tools. For further information, please visit our website www.mwg-biotech.com

Press releases you might also be interested in

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.